Impact of eligibility criteria discordance on clinical trial accrual in diffuse large B-cell lymphoma (DLBCL).
Conferences
Anderson, CE; Wang, M; Wuliji, N; Patel, AA; Lin, C
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2024
Volume
42
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Anderson, C. E., Wang, M., Wuliji, N., Patel, A. A., & Lin, C. (2024). Impact of eligibility criteria discordance on clinical trial accrual in diffuse large B-cell lymphoma (DLBCL). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).
Anderson, Clare E., Mei Wang, Natalie Wuliji, Anand Ashwin Patel, and Chenyu Lin. “Impact of eligibility criteria discordance on clinical trial accrual in diffuse large B-cell lymphoma (DLBCL).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.
Anderson CE, Wang M, Wuliji N, Patel AA, Lin C. Impact of eligibility criteria discordance on clinical trial accrual in diffuse large B-cell lymphoma (DLBCL). In: JOURNAL OF CLINICAL ONCOLOGY. 2024.
Anderson, Clare E., et al. “Impact of eligibility criteria discordance on clinical trial accrual in diffuse large B-cell lymphoma (DLBCL).” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.
Anderson CE, Wang M, Wuliji N, Patel AA, Lin C. Impact of eligibility criteria discordance on clinical trial accrual in diffuse large B-cell lymphoma (DLBCL). JOURNAL OF CLINICAL ONCOLOGY. 2024.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2024
Volume
42
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis